Readiness for HIV Postexposure Prophylaxis (PEP) Decision Making Following Sexual Violence

被引:0
|
作者
Moret, Jessica Draughon [1 ]
Wilson, Machelle [2 ]
Humphrey-Staub, Jacke [1 ]
Porter, Tequila [1 ]
Wellington, Jessica [3 ]
Anderson, Jocelyn C. [4 ]
机构
[1] Univ Calif Davis, Betty Irene Moore Sch Nursing, Davis, CA 95616 USA
[2] Univ Calif Davis, Clin & Translat Sci Ctr, Dept Publ Hlth Sci, Div Biostat, Davis, CA USA
[3] Penn State Univ, Nese Coll Nursing, University Pk, PA USA
[4] Univ Arkansas Med Sci, Coll Nursing, Little Rock, AR USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; MULTIDIMENSIONAL SCALE; ANTIRETROVIRAL THERAPY; MALE VICTIMS; ASSAULT; ADHERENCE; PREVENTION; EXPOSURE; RAPE; PREVALENCE;
D O I
10.1080/01612840.2024.2366324
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
HIV post-exposure prophylaxis (PEP) can reduce the risk of acquiring HIV infection following sexual assault. However, only about half of people offered HIV PEP will initiate the medication. Factors associated with patient readiness for HIV PEP following sexual assault have been attributed to structural and clinical barriers. This study utilized the Theory of Reasoned Action and Planned Behavior to better understand how personal factors, cognitive factors, mental health, barriers and facilitators that could influence a patient's decision to start HIV PEP post sexual assault. A web-based cross sectional survey was conducted from October 2017 to January 2020 and a total of 228 responses were included from participants that had experienced sexual assault in the previous 3 months. Using linear regression modeling fear of HIV, post-traumatic stress symptoms, validating social responses to disclosure, and having someone else pay for HIV PEP were all associated with feeling better prepared for HIV PEP decision making. Results indicate that structural, social, and individual factors impact patient decision making. These findings highlight opportunities for health systems and providers to improve HIV education and the importance of initiating HIV PEP following sexual assault.
引用
收藏
页码:937 / 947
页数:11
相关论文
共 50 条
  • [41] Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: The San Francisco PEP study
    Kahn, JO
    Martin, JN
    Roland, ME
    Bamberger, JD
    Chesney, M
    Chambers, D
    Franses, K
    Coates, TJ
    Hatz, MH
    JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (05): : 707 - 714
  • [42] Postexposure prophylaxis after sexual exposure to HIV in four accident and emergency departments in one region
    Arkell, P.
    Abouyannis, M.
    Manavi, K.
    HIV MEDICINE, 2011, 12 : 17 - 17
  • [43] Antiretroviral Prophylaxis following Sexual HIV Exposure in Italy
    Puro, V.
    De Carli, G.
    Schifano, E.
    Piselli, P.
    Franco, A.
    Niero, F.
    Signorini, L.
    Ippolito, G.
    INFECTION, 2010, 38 : 30 - 31
  • [44] Post-HIV exposure prophylaxis (PEP) regimens for Africa tested by decision analysis
    Freers, J
    Kellett, J
    Mayanja-Kizza, H
    XIV INTERNATIONAL AIDS CONFERENCE: INTERVENTIONS AND PROGRAM IMPLEMENTATION, 2002, : 125 - 130
  • [45] HIV seroconversion in a health care worker who underwent postexposure prophylaxis following needlestick injury
    Borba Brum, Maria Carlota
    Dantas Filho, Fabio Fernandes
    Yates, Zaira Balem
    Vercoza Viana, Maria Cecilia
    Martin Chaves, Eunice Beatriz
    Trindade, Damasio Macedo
    AMERICAN JOURNAL OF INFECTION CONTROL, 2013, 41 (05) : 471 - 472
  • [46] Trends in HIV postexposure prophylaxis prescription and compliance after sexual exposure in Amsterdam, 2000-2004
    Sonder, Gerard J. B.
    Van den Hoek, Anneke
    Regez, Rosa M.
    Brinkman, Kees
    Prins, Jan M.
    Mulder, Jan-Willem
    Veenstra, Jan
    Claessen, Frans A.
    Coutinho, Roel A.
    SEXUALLY TRANSMITTED DISEASES, 2007, 34 (05) : 288 - 293
  • [47] Use of rapid HIV testing in conjunction with a World Wide Web enabled expert system for managing occupational Postexposure Prophylaxis (PEP)
    Vazirani, B
    Mathew, P
    Kuo, YH
    John, JF
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 268 - 268
  • [48] Raltegravir, Tenofovir DF, and Emtricitabine for Postexposure Prophylaxis to Prevent the Sexual Transmission of HIV: Safety, Tolerability, and Adherence
    Mayer, Kenneth H.
    Mimiaga, Matthew J.
    Gelman, Marcy
    Grasso, Chris
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2012, 59 (04) : 354 - 359
  • [49] What are the characteristics of, and clinical outcomes in men who have sex with men prescribed HIV postexposure prophylaxis following sexual exposure (PEPSE) at sexual health clinics in England?
    Mitchell, Holly
    Furegato, Martina
    Hughes, Gwenda
    Field, Nigel
    Nardone, Anthony
    SEXUALLY TRANSMITTED INFECTIONS, 2017, 93 (03) : 207 - 213
  • [50] Assessment of Decision-Making Priorities for Patients and Providers Regarding HIV Post-Exposure Prophylaxis Following Sexual Assault: A Qualitative Study presented by
    Anderson, Jocelyn
    NURSING RESEARCH, 2021, 70 (03) : E74 - E74